Alison Dennis focuses on competition &
EU regulatory law. She provides intellectual property, commercial and expert
regulatory advice to clients in the pharmaceutical, biotech and
medical device industries at all stages during the life cycle of
their products.
Alison has extensive experience of drafting and negotiating a
wide range of specialist agreements for clients in the life sciences sector
including strategic alliances, collaborations, clinical trial
agreements, technical/quality agreements, tolling, manufacturing,
and supply agreements. Alison’s practice also includes advising on
the protection and exploitation of intellectual property rights
through a variety of different structures, where clients have
confirmed that Alison “does a great job” (The Legal
500, 2008).
Alison’s experience includes advising on a wide range of
regulatory issues arising in the pharmaceutical, biotech and
medical device industries. These include complex issues arising in
connection with compliance with the various codes of practice on
advertising and promoting pharmaceuticals and medical devices,
establishment in the EU, the regulation of clinical trials, the
regulation of human tissue use, and dealings with the Medicines and
Healthcare products Regulatory Agency (MHRA) and the European
Medicines Agency (EMEA).
Alison is a regular speaker at international conferences on
compliance issues affecting the pharmaceutical and medical devices
industries.
Alison sits on the Legal Committee and the Compliance Working
Group of the ABHI (UK trade association for medical devices
industry).
Alison speaks English and French (fluent).